EE434 Evaluating the Budget Impact of Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) in Patients With Moderate to Severe Asthma in the Saudi Healthcare System
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.817
https://www.valueinhealthjournal.com/article/S1098-3015(25)03374-1/fulltext
Title :
EE434 Evaluating the Budget Impact of Single Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) in Patients With Moderate to Severe Asthma in the Saudi Healthcare System
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03374-1&doi=10.1016/j.jval.2025.09.817
First page :
Section Title :
Open access? :
No
Section Order :
10385